Abbott Laboratories
Abbott Laboratories is a company.
Active
Updated: ·
About
Abbott Laboratories is a company.
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Abbott Laboratories.
Abbott Laboratories is a company.
Abbott Laboratories is a company.
Key people at Abbott Laboratories.
Abbott Laboratories is a global healthcare company specializing in medical devices, diagnostics, nutritional products, and pharmaceuticals, with a mission to help people live healthier, fuller lives through innovative health technologies.[1][2][4] Founded in 1888, it employs about 114,000 people across 160+ countries, operates 31 manufacturing sites and 12 development centers worldwide, and focuses on areas like cardiovascular care, diabetes management, neuromodulation, and chronic pain relief, with top products including heart stents, the MitraClip valve repair system, FreeStyle blood glucose monitors, and nutritional brands like Ensure and Pedialyte.[1][2][4] Headquartered in Abbott Park, Chicago, under CEO Robert B. Ford, the company has demonstrated strong growth through strategic acquisitions and a separation from AbbVie in 2013 to sharpen its focus on devices and diagnostics.[1][2]
Abbott Laboratories traces its roots to 1888, when Wallace C. Abbott, a 30-year-old practicing physician, drugstore owner, and 1885 University of Michigan graduate, founded the Abbott Alkaloidal Company in Ravenswood, Chicago.[1][2][3][4][7] Frustrated by inconsistent liquid plant-based medicines, Abbott innovated "dosimetric granules" extracting precise alkaloid doses from plants like morphine and quinine, achieving $2,000 in first-year sales and incorporating in 1894.[1][2][3] Early expansion included a 1907 London office and 1916's synthetic antiseptic Chlorazene for World War I soldiers; post-war, it capitalized on U.S. manufacturing of German drugs like veronal, boosting sales to $1.4 million by 1918.[1][3] The company relocated to North Chicago in 1922, grew internationally (e.g., Canada, India, Pakistan), acquired Ross Laboratories for nutritional products like Similac, and evolved through diagnostics innovations from the 1970s onward, culminating in the 2013 AbbVie spin-off and 2017 acquisitions of St. Jude Medical and Alere for $28+ billion to bolster devices and diagnostics.[1][2]
Abbott rides the wave of personalized health tech and digital diagnostics, capitalizing on aging populations, rising chronic diseases (diabetes, cardiovascular), and post-pandemic demand for at-home monitoring and rapid testing.[1][4][5] Its timing aligns with shifts from pharmaceuticals to devices—exemplified by the 2013 AbbVie split and 2017 acquisitions—positioning it amid market forces like AI-integrated diagnostics, telemedicine growth, and supply chain localization post-COVID.[1][2] Abbott influences the ecosystem by advancing lab standards (e.g., 1970s hepatitis tests, ABA-100 analyzer) and global health partnerships for disease prevention, employing 114,000 to drive innovations that enable breakthroughs in consumer health.[4][5]
Abbott is poised for expansion in connected health ecosystems, with trends like AI-enhanced diagnostics, wearable integration for real-time monitoring, and emerging markets fueling growth beyond its $20+ billion annual scale.[1][3][4] Expect deeper penetration in structural heart repairs, point-of-care testing, and nutrition for longevity, potentially through more acquisitions amid regulatory tailwinds for medtech. Its influence will evolve as a bridge between traditional pharma and digital health, sustaining its 135-year legacy of turning human needs into scalable solutions, much like Wallace Abbott's granules revolutionized dosing over a century ago.[2][4]
Key people at Abbott Laboratories.
